CONMED Corporation
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $47.1M | $132.4M | $64.5M | $-80.6M | $62.5M | $9.5M | $28.6M | $40.9M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $17.1M | $16.6M | $16.2M | $16.1M | $16.5M | $18.0M | $18.7M | $18.5M |
| Amortization | $35.2M | $34.7M | $35.2M | $33.7M | $33.3M | $34.2M | $32.3M | $23.2M |
| Stock-Based Compensation | $28.3M | $25.6M | $24.3M | $21.7M | $16.3M | $13.1M | $11.8M | $10.0M |
| Net Cash from Operating Activities | $170.7M | $167.0M | $125.3M | $33.4M | $111.8M | $64.5M | $95.1M | $74.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $19.8M | $13.1M | $19.0M | $21.8M | $14.9M | $13.0M | $20.1M | $16.5M |
| Business Acquisitions | — | $0 | $0 | $227.7M | $0 | — | — | — |
| Net Cash from Investing Activities | $-21.0M | $-13.1M | $-20.0M | $-249.5M | $-14.9M | $-13.6M | $-387.7M | $-16.5M |
| Financing Activities | ||||||||
| Dividends Paid | $24.7M | $24.7M | $24.5M | $24.0M | $23.3M | $22.8M | $22.6M | $22.4M |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-135.8M | $-151.0M | $-110.4M | $225.0M | $-101.5M | $-52.1M | $300.9M | $-72.3M |
| Net Change in Cash | $16.4M | $163.0K | $-4.6M | $8.1M | $-6.5M | $1.5M | $8.3M | $-15.1M |
| Free Cash Flow | $150.9M | $153.9M | $106.3M | $11.6M | $96.9M | $51.5M | $75.1M | $58.2M |